Low wages and a lack of respect are the biggest reasons employers are having a hard time retaining and keeping nurses, according to a new industry survey.
AMDA calls for public list of nursing home industry’s ‘underutilized’ and ‘invisible’ medical...
By
Alicia Lasek
Mar 07, 2022
President Biden’s call for nursing home reform must extend to the industry’s clinical leadership as well, a top clinician advocate contends. A public directory would be a step toward transparency...
Small building proponents embrace Biden’s nursing home overhaul plan
By
Alicia Lasek
Mar 07, 2022
The proposed phase-out of multiple-occupancy rooms is crucial to helping prevent uncontrolled infectious disease outbreaks, the Green House Project says.
Private investment crucial to achieve capital improvements at SNFs: legal expert
By
Danielle Brown
Mar 07, 2022
The federal government needs a better understanding of private investment in nursing homes and the role it plays in capital and quality improvements, a leading legal expert says. This is especially true...
Reform policies ‘double down’ on decades-long failures, LTC physicians warn
By
Danielle Brown
Mar 07, 2022
The Biden administration’s approach toward nursing home reform uses the unsuccessful and “punitive” tactics that haven’t proved to advance quality for years, according to a top industry group.
Stable use of antipsychotics in long-term care during pandemic ‘reassuring’: study
By
Kimberly Bonvissuto
Mar 07, 2022
The use of antipsychotics and pain medications in assisted living and nursing home residents was relatively unchanged early in the pandemic. New residents were more likely to get certain drugs, however.
Clinical briefs for Monday, March 7
By
Alicia Lasek
Mar 07, 2022
Almost a third of recovered COVID-19 patients report symptoms lasting 6 to 12 months … States saddled with unused COVID-19 vaccines; CDC advises docs to discard doses … Typical post-acute care user...
‘They heard us’: Partner program to allow fast LTC access to federal stock of COVID-19 drugs
By
Alicia Lasek
Mar 04, 2022
The federal Long-Term Care Partner Program aims to quickly get time-sensitive COVID-19 treatments to facilities when an outbreak occurs. The first drug available via the portal will be molnupiravir, followed...
Omicron sub-variants cut potency of monoclonal antibodies, mRNA vaccines: study
Mar 04, 2022
Eli Lilly’s bebtelovimab is the only authorized monoclonal antibody that can neutralize all three dominant sub-variants, investigators say.
More U.S. adults using melatonin as sleep aid despite lack of evidence
Mar 04, 2022
Use of the supplement melatonin by U.S. adults has more than quintupled between 1999 and 2018, a new study has found.